DrugPatentWatch Database Preview
Details for Patent: 8,425,934
Which drugs does patent 8,425,934 protect, and when does it expire?
Patent 8,425,934 protects BRILINTA and is included in one NDA.
This patent has forty-four patent family members in thirty-four countries.
Summary for Patent: 8,425,934
| Title: | Pharmaceutical compositions |
| Abstract: | The present invention relates to pharmaceutical compositions and, more particularly, to a pharmaceutical composition containing the compound {1S-[1.alpha.,2.alpha.,3.beta.(1S*,2R*),5.beta.]}-3-(7-{[2-(3,4-difluorop- henyl)cyclopropyl]amino}-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-- 3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol. |
| Inventor(s): | Banks; Simon (Loughborough, GB) |
| Assignee: | AstraZeneca AB (Sodertalje, SE) |
| Application Number: | 11/841,030 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,425,934 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; Dosage form; |
Drugs Protected by US Patent 8,425,934
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Pharms | BRILINTA | ticagrelor | TABLET;ORAL | 022433-002 | Sep 3, 2015 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Astrazeneca Pharms | BRILINTA | ticagrelor | TABLET;ORAL | 022433-001 | Jul 20, 2011 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,425,934
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 062451 | Start Trial | |||
| Australia | 2007288541 | Start Trial | |||
| Australia | 2011205164 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
